Evidence map›Paper›PMID 16236241›Full record

ArticleAnalytical biochemistry2005

Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.

Ding Wu, Evan Nair-Gill, Dorie A Sher, Laurie L Parker, Jennifer M Campbell, Mariah Siddiqui, Wendy Stock, Stephen J Kron

Abstract read
In one paragraph

Article in Analytical biochemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Phosphoprotein profiling by PA-GeLC-MS/MS.Journal of proteome research · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ding WuCenter for Molecular Oncology and Department of Molecular Genetics and Cell Biology, University of Chicago, IL 60637, USA.
Evan Nair-Gill
Dorie A Sher
Laurie L Parker
Jennifer M Campbell
Mariah Siddiqui
Wendy Stock
Stephen J Kron
University of Chicago · USMolecular Oncology (United States) · US

Funding

BCR-ABL Kinase Assays for STI571 Sensitivity of ResponseR33CA103235 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2004 to 2006
$1.6M
BCR-ABL Kinase Assays for STI571 Sensitivity of ResponseR21CA103235 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2003 to 2003
$153k
Bcr-Abl thiophosphorylation profiling in CML using MALDIF32CA117672 · NCI · UNIVERSITY OF CHICAGO · PI PARKER, LAURIE L. · 2005 to 2006
$93k
NCI NIH HHS F32 CA117672NCI NIH HHS R21 CA103235NCI NIH HHS R33 CA10323NCI NIH HHS R33 CA103235PHS HHS T32
6 · The paper itself

Abstract

There is a current and increasing demand for simple, robust, nonradioactive assays of protein tyrosine kinase activity with applications for clinical diagnosis and high-throughput screening of potential molecularly targeted therapeutic agents. One significant challenge is to detect and measure the activity of specific kinases with key roles in cell signaling as an approach to distinguish normal cells from cancer cells and as a means of evaluating targeted drug efficacy and resistance in cancer cells. Here, we describe a method in which kinase substrates fused to glutathione-S-transferase and immobilized on glutathione agarose beads are phosphorylated, eluted, and then assayed to detect kinase activity. The activity of recombinant, purified c-Abl kinase or Bcr-Abl kinase in whole cell extracts can be detected with equivalent specificity, sensitivity, and reproducibility. Similarly, inhibition of recombinant c-Abl or Bcr-Abl in cells or cell extracts by imatinib mesylate and other Bcr-Abl targeted kinase inhibitors is readily assayed. This simple kinase assay is sufficiently straightforward and robust for use in clinical laboratories and is potentially adaptable to high-throughput assay formats.

Indexed as

MicrospheresAmino Acid SequenceAnimalsBenzamidesCell ExtractsCells, CulturedFusion Proteins, bcr-ablGlutathione TransferaseImatinib MesylateMiceMolecular Sequence DataPhosphorylationPiperazinesProtein Kinase InhibitorsProtein-Tyrosine KinasesPyrimidinesBenzamidesCell ExtractsFusion Proteins, bcr-ablGlutathione TransferaseImatinib MesylatePiperazinesProtein Kinase InhibitorsProtein-Tyrosine KinasesPyrimidinesSepharose

Identifiers

PMID16236241
PMCPMC4562293
OpenAlexW2052802421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.